| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neovascularization, Pathologic | 4 | 2021 | 305 | 1.59 | Why? |
| Hypertension, Pulmonary | 5 | 2019 | 970 | 0.99 | Why? |
| Hemangioma, Capillary | 1 | 2019 | 17 | 0.78 | Why? |
| Pulmonary Veno-Occlusive Disease | 1 | 2019 | 28 | 0.77 | Why? |
| Endothelium, Vascular | 3 | 2020 | 1751 | 0.76 | Why? |
| In Situ Hybridization, Fluorescence | 1 | 2019 | 207 | 0.71 | Why? |
| Lung Diseases, Interstitial | 2 | 2019 | 1476 | 0.70 | Why? |
| Pulmonary Veins | 1 | 2019 | 146 | 0.68 | Why? |
| Arthritis, Infectious | 1 | 2019 | 111 | 0.67 | Why? |
| Autopsy | 7 | 2021 | 3495 | 0.66 | Why? |
| Lung Transplantation | 5 | 2019 | 1554 | 0.65 | Why? |
| Microvessels | 1 | 2021 | 490 | 0.65 | Why? |
| Pulmonary Fibrosis | 3 | 2019 | 1068 | 0.57 | Why? |
| Prosthesis-Related Infections | 1 | 2019 | 302 | 0.57 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.42 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2021 | 2984 | 0.38 | Why? |
| Lung | 13 | 2021 | 31049 | 0.38 | Why? |
| Receptors, Interferon | 2 | 2017 | 64 | 0.35 | Why? |
| Factor XII | 2 | 2017 | 26 | 0.35 | Why? |
| PPAR gamma | 2 | 2018 | 102 | 0.33 | Why? |
| Organ Transplantation | 1 | 2019 | 2616 | 0.26 | Why? |
| Hepatitis, Autoimmune | 2 | 2018 | 254 | 0.25 | Why? |
| fms-Like Tyrosine Kinase 3 | 2 | 2019 | 43 | 0.24 | Why? |
| Swine, Miniature | 2 | 2018 | 33 | 0.23 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.22 | Why? |
| Dinoprostone | 1 | 2021 | 101 | 0.21 | Why? |
| Aprotinin | 1 | 2020 | 63 | 0.21 | Why? |
| Myelopoiesis | 1 | 2021 | 116 | 0.21 | Why? |
| Thoracic Diseases | 1 | 2020 | 118 | 0.20 | Why? |
| Uveal Neoplasms | 1 | 2019 | 26 | 0.19 | Why? |
| Graft Rejection | 3 | 2019 | 1766 | 0.19 | Why? |
| Pulmonary Valve | 1 | 2019 | 31 | 0.19 | Why? |
| Dendritic Cells | 2 | 2019 | 1330 | 0.19 | Why? |
| Cytotoxicity Tests, Immunologic | 1 | 2018 | 32 | 0.19 | Why? |
| Paraffin Embedding | 1 | 2019 | 105 | 0.19 | Why? |
| Esters | 1 | 2021 | 300 | 0.19 | Why? |
| Cell Proliferation | 3 | 2017 | 1973 | 0.19 | Why? |
| Endothelial Cells | 3 | 2021 | 2048 | 0.18 | Why? |
| Consensus Development Conferences as Topic | 1 | 2018 | 93 | 0.18 | Why? |
| Organ Preservation | 1 | 2018 | 49 | 0.18 | Why? |
| Mediastinal Diseases | 1 | 2018 | 38 | 0.18 | Why? |
| Hypergammaglobulinemia | 1 | 2017 | 5 | 0.18 | Why? |
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2017 | 17 | 0.18 | Why? |
| Pulmonary Embolism | 1 | 2017 | 4775 | 0.18 | Why? |
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 75 | 0.18 | Why? |
| Secondary Metabolism | 1 | 2017 | 61 | 0.17 | Why? |
| Transplantation Tolerance | 1 | 2017 | 13 | 0.17 | Why? |
| Bone Morphogenetic Protein 2 | 1 | 2017 | 24 | 0.17 | Why? |
| Mycobacterium Infections | 1 | 2017 | 72 | 0.17 | Why? |
| Collagen | 1 | 2019 | 222 | 0.17 | Why? |
| Mediastinum | 1 | 2018 | 122 | 0.17 | Why? |
| Perfusion | 1 | 2018 | 254 | 0.17 | Why? |
| Pathology, Molecular | 1 | 2020 | 343 | 0.17 | Why? |
| Vascular Remodeling | 1 | 2017 | 99 | 0.17 | Why? |
| Extracorporeal Circulation | 1 | 2018 | 130 | 0.16 | Why? |
| Microscopy, Electron, Scanning | 1 | 2017 | 221 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Microscopy, Confocal | 1 | 2018 | 343 | 0.16 | Why? |
| Mycobacterium bovis | 1 | 2017 | 125 | 0.16 | Why? |
| Guanidines | 1 | 2021 | 499 | 0.16 | Why? |
| Angiography | 1 | 2017 | 301 | 0.16 | Why? |
| Myocytes, Smooth Muscle | 1 | 2017 | 127 | 0.15 | Why? |
| Everolimus | 1 | 2018 | 215 | 0.15 | Why? |
| Uropathogenic Escherichia coli | 1 | 2015 | 10 | 0.15 | Why? |
| Radiosurgery | 1 | 2019 | 249 | 0.15 | Why? |
| Interleukin-2 | 1 | 2018 | 443 | 0.15 | Why? |
| Pathology, Clinical | 1 | 2020 | 407 | 0.15 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.15 | Why? |
| Carotid Arteries | 1 | 2017 | 182 | 0.15 | Why? |
| Tissue Engineering | 1 | 2017 | 190 | 0.15 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.15 | Why? |
| Epididymitis | 1 | 2015 | 39 | 0.14 | Why? |
| Imaging, Three-Dimensional | 1 | 2020 | 680 | 0.14 | Why? |
| Serine Endopeptidases | 2 | 2021 | 4606 | 0.14 | Why? |
| Protective Agents | 1 | 2017 | 250 | 0.14 | Why? |
| Leukocytes | 2 | 2019 | 1046 | 0.14 | Why? |
| Hematopoietic Stem Cells | 1 | 2017 | 321 | 0.14 | Why? |
| Heart Valve Diseases | 1 | 2019 | 355 | 0.14 | Why? |
| Humans | 42 | 2021 | 930598 | 0.14 | Why? |
| Disease Models, Animal | 5 | 2019 | 10998 | 0.14 | Why? |
| Pulmonary Edema | 1 | 2018 | 430 | 0.13 | Why? |
| alpha 1-Antitrypsin | 1 | 2017 | 264 | 0.13 | Why? |
| Signal Transduction | 4 | 2019 | 7207 | 0.13 | Why? |
| Pneumonia, Pneumococcal | 1 | 2017 | 251 | 0.13 | Why? |
| Clinical Laboratory Services | 1 | 2020 | 781 | 0.13 | Why? |
| Pulmonary Artery | 2 | 2017 | 803 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.13 | Why? |
| Genetic Therapy | 1 | 2017 | 409 | 0.13 | Why? |
| Biopsy | 2 | 2020 | 2811 | 0.12 | Why? |
| Heart Valve Prosthesis | 1 | 2019 | 533 | 0.12 | Why? |
| Glucose | 1 | 2017 | 573 | 0.12 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.12 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.12 | Why? |
| Mice, Inbred C57BL | 6 | 2019 | 5542 | 0.12 | Why? |
| Aortic Valve | 1 | 2019 | 664 | 0.12 | Why? |
| Lymphadenopathy | 1 | 2018 | 444 | 0.12 | Why? |
| Cells, Cultured | 6 | 2021 | 5835 | 0.11 | Why? |
| Streptococcus pneumoniae | 1 | 2017 | 827 | 0.11 | Why? |
| Lymph Nodes | 1 | 2018 | 1060 | 0.11 | Why? |
| Bronchi | 1 | 2018 | 1048 | 0.11 | Why? |
| Growth Differentiation Factor 15 | 1 | 2011 | 89 | 0.11 | Why? |
| Heart | 1 | 2021 | 1791 | 0.11 | Why? |
| Transplantation, Homologous | 3 | 2019 | 757 | 0.11 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| Down-Regulation | 1 | 2017 | 1416 | 0.11 | Why? |
| Ventricular Dysfunction, Right | 1 | 2018 | 639 | 0.11 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.11 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Predictive Value of Tests | 3 | 2020 | 9537 | 0.10 | Why? |
| Inflammation Mediators | 2 | 2018 | 2654 | 0.10 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.10 | Why? |
| Female | 20 | 2021 | 380317 | 0.10 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2019 | 2483 | 0.09 | Why? |
| Macrophages | 2 | 2017 | 2784 | 0.09 | Why? |
| Animals | 16 | 2021 | 78931 | 0.09 | Why? |
| Mice, Knockout | 3 | 2019 | 1815 | 0.09 | Why? |
| Immunohistochemistry | 4 | 2017 | 2275 | 0.09 | Why? |
| Ferritins | 1 | 2017 | 2055 | 0.09 | Why? |
| Germany | 2 | 2020 | 9196 | 0.09 | Why? |
| Melanoma | 1 | 2019 | 1229 | 0.09 | Why? |
| Interferon-gamma | 1 | 2017 | 2711 | 0.08 | Why? |
| Male | 18 | 2021 | 367725 | 0.08 | Why? |
| Proof of Concept Study | 2 | 2020 | 696 | 0.08 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
| Transcriptome | 1 | 2019 | 3466 | 0.08 | Why? |
| Mice | 7 | 2019 | 21357 | 0.08 | Why? |
| Membrane Proteins | 3 | 2021 | 1733 | 0.08 | Why? |
| Europe | 2 | 2020 | 12702 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2021 | 3630 | 0.07 | Why? |
| Swine | 3 | 2018 | 3352 | 0.07 | Why? |
| Graft Survival | 2 | 2018 | 587 | 0.07 | Why? |
| Blood Coagulation | 1 | 2017 | 2768 | 0.07 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2017 | 2426 | 0.07 | Why? |
| Immunosuppressive Agents | 2 | 2019 | 6331 | 0.06 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.06 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.06 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.06 | Why? |
| Iron | 2 | 2018 | 619 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
| Fibroblast Growth Factor 2 | 1 | 2021 | 77 | 0.06 | Why? |
| Apoptosis | 1 | 2011 | 2335 | 0.05 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.05 | Why? |
| Tropism | 1 | 2021 | 210 | 0.05 | Why? |
| Vero Cells | 3 | 2021 | 14117 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.05 | Why? |
| Serine Proteases | 1 | 2021 | 211 | 0.05 | Why? |
| Organ Preservation Solutions | 1 | 2018 | 20 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Transplantation, Heterologous | 1 | 2019 | 77 | 0.05 | Why? |
| Histocompatibility Antigens | 1 | 2018 | 38 | 0.05 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.05 | Why? |
| Physiology, Comparative | 1 | 2017 | 2 | 0.05 | Why? |
| Cyclotrons | 1 | 2017 | 2 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2020 | 7301 | 0.05 | Why? |
| Mycobacterium avium | 1 | 2017 | 10 | 0.05 | Why? |
| Animals, Newborn | 1 | 2019 | 350 | 0.05 | Why? |
| Cytokines | 2 | 2017 | 15010 | 0.04 | Why? |
| Gelatinases | 1 | 2017 | 7 | 0.04 | Why? |
| Tissue Array Analysis | 1 | 2017 | 75 | 0.04 | Why? |
| Etanercept | 1 | 2019 | 162 | 0.04 | Why? |
| Tissue Donors | 2 | 2018 | 1679 | 0.04 | Why? |
| Transplantation Chimera | 1 | 2017 | 17 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2019 | 22971 | 0.04 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2019 | 286 | 0.04 | Why? |
| Nasopharynx | 1 | 2017 | 10224 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Hepatocyte Growth Factor | 1 | 2017 | 71 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2017 | 316 | 0.04 | Why? |
| Vasoconstriction | 1 | 2018 | 153 | 0.04 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2021 | 604 | 0.04 | Why? |
| Antibiotics, Antineoplastic | 1 | 2017 | 128 | 0.04 | Why? |
| Hepcidins | 1 | 2017 | 97 | 0.04 | Why? |
| Organ Specificity | 1 | 2021 | 1070 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2017 | 86 | 0.04 | Why? |
| Bleomycin | 1 | 2017 | 195 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2020 | 1236 | 0.04 | Why? |
| Serine Proteinase Inhibitors | 1 | 2020 | 341 | 0.04 | Why? |
| Spectroscopy, Fourier Transform Infrared | 1 | 2017 | 207 | 0.04 | Why? |
| Retrospective Studies | 5 | 2019 | 105322 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| THP-1 Cells | 1 | 2017 | 374 | 0.04 | Why? |
| Virus Activation | 1 | 2021 | 480 | 0.04 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.04 | Why? |
| Prosthesis Design | 1 | 2019 | 594 | 0.04 | Why? |
| Enteropathogenic Escherichia coli | 1 | 2015 | 11 | 0.04 | Why? |
| Epididymis | 1 | 2015 | 23 | 0.04 | Why? |
| Extracellular Matrix | 1 | 2017 | 189 | 0.04 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.04 | Why? |
| Tissue Scaffolds | 1 | 2017 | 174 | 0.04 | Why? |
| Horses | 1 | 2017 | 474 | 0.04 | Why? |
| Chemokine CCL2 | 1 | 2018 | 389 | 0.04 | Why? |
| Oxidation-Reduction | 1 | 2018 | 540 | 0.04 | Why? |
| Rats, Wistar | 1 | 2017 | 621 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| von Willebrand Factor | 1 | 2021 | 668 | 0.04 | Why? |
| Cryopreservation | 1 | 2019 | 464 | 0.04 | Why? |
| Models, Animal | 1 | 2018 | 788 | 0.04 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.03 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.03 | Why? |
| Eye | 1 | 2019 | 374 | 0.03 | Why? |
| Cyclosporine | 1 | 2018 | 449 | 0.03 | Why? |
| Ligands | 1 | 2019 | 1300 | 0.03 | Why? |
| Infant, Premature | 1 | 2019 | 883 | 0.03 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.03 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 449 | 0.03 | Why? |
| Immunologic Deficiency Syndromes | 1 | 2017 | 368 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| Allografts | 1 | 2017 | 761 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Proteolysis | 1 | 2017 | 751 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Wound Healing | 1 | 2017 | 424 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.03 | Why? |
| Spleen | 1 | 2017 | 877 | 0.03 | Why? |
| Microdissection | 1 | 2011 | 9 | 0.03 | Why? |
| Immune Tolerance | 1 | 2017 | 608 | 0.03 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.03 | Why? |
| United States | 1 | 2018 | 46150 | 0.03 | Why? |
| Stress, Mechanical | 1 | 2011 | 143 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2017 | 1647 | 0.03 | Why? |
| Familial Primary Pulmonary Hypertension | 1 | 2011 | 68 | 0.03 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.03 | Why? |
| Cell Hypoxia | 1 | 2011 | 141 | 0.03 | Why? |
| Registries | 2 | 2021 | 12327 | 0.03 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.03 | Why? |
| Neovascularization, Physiologic | 1 | 2011 | 160 | 0.03 | Why? |
| Bronchoscopy | 1 | 2018 | 991 | 0.03 | Why? |
| Area Under Curve | 1 | 2017 | 2564 | 0.02 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Rats | 1 | 2017 | 2764 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2021 | 4020 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Analysis of Variance | 1 | 2011 | 950 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Monocytes | 1 | 2019 | 2978 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2017 | 2585 | 0.02 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.02 | Why? |
| Protein Domains | 1 | 2017 | 6563 | 0.02 | Why? |
| Child, Preschool | 2 | 2019 | 36283 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.02 | Why? |
| Antibody Formation | 1 | 2017 | 4038 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Up-Regulation | 1 | 2011 | 2249 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.01 | Why? |
| Time Factors | 2 | 2017 | 31397 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2011 | 3786 | 0.01 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.01 | Why? |
| Child | 2 | 2019 | 70012 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2019 | 6653 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 13720 | 0.01 | Why? |